BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 28, 2019
View Archived Issues
Toughening up amyloid fibrils
Read More
New genetic alphabet doubles the fun
Read More
Cell Medica awarded grant for development of CAR-NK T-cell therapy
Read More
Correlation of immune characteristics with immune control and treatment efficacy in herpes labialis
Read More
Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis
Read More
Improved lymphocyte access via development of a lymphatic-targeted dosing system
Read More
Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury
Read More
Beactica, VIB and CD3 enter drug discovery alliance
Read More
Sarepta Therapeutics announces preliminary results from first cohort in phase I/II study of MYO-101
Read More
Foamix presents positive safety and efficacy data from phase III study of FMX-103
Read More
Double dose of suicide genes increases beta-cell safety, efficacy
Read More
Dual adenosine receptor A2A/A2B receptor antagonists described by Merck & Co.
Read More
C/EBPdelta identified as a therapeutic target for IVIG-resistant Kawasaki disease
Read More
Improved safety and efficacy of a second-generation diphtheria toxin-based fusion protein
Read More
CytomX Therapeutics gives program highlights for CX-072 and CX-2009
Read More
Eisai to support AAR Japan program to raise awareness of mycetoma in Sudan
Read More
Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors
Read More
B7-H3.CAR-Ts demonstrate promising efficacy and safety in preclinical cancer models
Read More
New PI3Kgmma and PI3Kdelta inhibitors discovered at Columbia University
Read More
Nodthera patents NLRP3 inflammasome inhibitors
Read More
First patient dosed ORIENT-32 study of Tyvyt plus IBI-305 in HCC
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery present AR antagonists
Read More
Miransertib shows promising therapeutic efficacy in children with Proteus syndrome
Read More
NIAID is recruiting participants in phase I study of VRC-FLUNPF099-00-VP influenza vaccine
Read More
Acurx presents first-in-human data for ACX-362E
Read More
Novavax's phase III Prepare study of ResVax misses primary objective
Read More
Horizon Pharma reports phase III OPTIC study data for teprotumumab
Read More
